Clinical trial
Ideal Marker for Targeted Axillary Dissection
NCT04580251 is registered in ClinicalTrials.gov with University Hospital Ostrava as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ideal Marker for Targeted Axillary Dissection
- Lead sponsor
- University Hospital Ostrava
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- May 30, 2023
- Enrollment
- 100 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer